For chronic weight management, the FDA-approved indications generally include adults with a BMI of 30 or greater, or BMI 27 or greater with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease)
If your digestive system is a highway, Semaglutide is that slow vehicle that jumps in front of you in the left lane
It indicates that the United States plays an important role in promoting the development of this field
& Blaslov, K
These product-level recommendations provide a relevant framework for clinical vigilance, but should not be assumed to apply directly to retatrutide until its own regulatory documentation is available
Even if your doctor said the drug was safe, manufacturers are responsible for providing adequate warnings